Marvel Biosciences Corp (MRVL)

Currency in CAD
0.18
-0.01(-5.56%)
Closed·
MRVL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.180.18
52 wk Range
0.080.19
Key Statistics
Bid/Ask
0.14 / 0.19
Prev. Close
0.18
Open
0.18
Day's Range
0.18-0.18
52 wk Range
0.08-0.19
Volume
1K
Average Volume (3m)
8.5K
1-Year Change
50%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MRVL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Marvel Biosciences Corp Company Profile

Marvel Biosciences Corp. is a Canada-based pre-clinical stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical derivatives of the original approved drug for the new disease indication. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The Company's lead compound, MB-204, is a novel fluorinated derivative of Istradefylline. The Company is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.

Compare MRVL to Peers and Sector

Metrics to compare
MRVL
Peers
Sector
Relationship
P/E Ratio
0.0x−2.7x−0.5x
PEG Ratio
0.000.040.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x2.3x3.3x
Upside (Analyst Target)
0.0%254.3%43.5%
Fair Value Upside
Unlock2.2%6.9%Unlock

Earnings

Latest Release
Mar 30, 2023
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MRVL Income Statement

FAQ

What Stock Exchange Does Marvel Biosciences Trade On?

Marvel Biosciences is listed and trades on the CBOE Canada Exchange stock exchange.

What Is the Stock Symbol for Marvel Biosciences?

The stock symbol for Marvel Biosciences is "MRVL."

What Is the Marvel Biosciences Market Cap?

As of today, Marvel Biosciences market cap is 10.69M.

What Is Marvel Biosciences's Earnings Per Share (TTM)?

The Marvel Biosciences EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is MRVL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Marvel Biosciences Stock Split?

Marvel Biosciences has split 0 times.

What is the current trading status of Marvel Biosciences (MRVL)?

As of 07 Aug 2025, Marvel Biosciences (MRVL) is trading at a price of 0.18, with a previous close of 0.18. The stock has fluctuated within a day range of 0.18 to 0.18, while its 52-week range spans from 0.08 to 0.19.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.